Heaf JG, et al. Increased incidence and improved prognosis of glomerulonephritis: A national 30-year study. Clin Kidney J 2020; 14:1594–1602. doi: 10.1093/ckj/sfaa169
Anders H-J, et al. Glomerulonephritis: Immunopathogenesis and immunotherapy. Nat Rev Immunol 2023; 23:453–471. doi: 10.1038/s41577-022-00816-y
Wetmore JB, et al. The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis. Kidney Int 2016; 90:853–860. doi: 10.1016/j.kint.2016.04.026
Lentine KL, et al. OPTN/SRTR 2020 Annual Data Report: Kidney. Am J Transplant 2022; 22(Suppl 2):21–136. doi: 10.1111/AJT.16982
Jiang SH, et al. Recurrent glomerulonephritis following renal transplantation and impact on graft survival. BMC Nephrol 2018; 19:344. doi: 10.1186/s12882-018-1135-7
Avery RK, et al. Quantifying infection risks in incompatible living donor kidney transplant recipients. Am J Transplant 2021; 21:1564–1575. doi: 10.1111/ajt.16316
Massicotte-Azarniouch D, et al. Infections following kidney transplantation after exposure to immunosuppression for treatment of glomerulonephritis. Am J Kidney Dis (published online December 30, 2023). doi: 10.1053/j.ajkd.2023.10.016
Roberts MB, Fishman JA. Immunosuppressive agents and infectious risk in transplantation: Managing the “net state of immunosuppression.” Clin Infect Dis 2021; 73:e1302–e1317. doi: 10.1093/cid/ciaa1189
Nambiar P, et al. Infection in kidney transplantation. In: Ramirez CGB, McCauley J. Contemporary Kidney Transplantation. 2018:307–327. https://link.springer.com/content/pdf/10.1007/978-3-319-19617-6_22.pdf